1. Home
  2. ARQT vs SAM Comparison

ARQT vs SAM Comparison

Compare ARQT & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.69

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Boston Beer Company Inc. (The)

SAM

Boston Beer Company Inc. (The)

HOLD

Current Price

$176.78

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
SAM
Founded
2016
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ARQT
SAM
Price
$23.69
$176.78
Analyst Decision
Strong Buy
Hold
Analyst Count
6
11
Target Price
$34.00
$233.70
AVG Volume (30 Days)
1.7M
273.5K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
88.79
95.45
EPS
N/A
N/A
Revenue
$376,072,000.00
$1,964,994,000.00
Revenue This Year
$34.85
$1.02
Revenue Next Year
$29.39
$1.31
P/E Ratio
N/A
N/A
Revenue Growth
91.34
N/A
52 Week Low
$12.72
$158.68
52 Week High
$31.77
$264.46

Technical Indicators

Market Signals
Indicator
ARQT
SAM
Relative Strength Index (RSI) 62.23 43.45
Support Level $22.41 $169.98
Resistance Level $23.87 $228.42
Average True Range (ATR) 0.85 6.89
MACD 0.34 2.00
Stochastic Oscillator 91.83 58.93

Price Performance

Historical Comparison
ARQT
SAM

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: